The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Can E-Health Improve Post-marketing Surveillance Of Drugs And Vaccines? The Stimulated Telephone Assisted Rapid Safety Surveillance (STARSS) Randomised Controlled Trial.
Funder
National Health and Medical Research Council
Funding Amount
$445,368.00
Summary
Despite the considerable benefits of vaccination there is public concern about the safety of newly introduced or seasonal influenza vaccines. Loss of confidence in vaccine safety can result in decreased vaccine coverage and resurgence of disease. The current system of monitoring vaccines after licensure is unable to detect all important adverse events following immunisation. The proposed study evaluates web based communication and mobile phone text messaging to identify adverse events following ....Despite the considerable benefits of vaccination there is public concern about the safety of newly introduced or seasonal influenza vaccines. Loss of confidence in vaccine safety can result in decreased vaccine coverage and resurgence of disease. The current system of monitoring vaccines after licensure is unable to detect all important adverse events following immunisation. The proposed study evaluates web based communication and mobile phone text messaging to identify adverse events following immunisation.Read moreRead less
Severe Influenza: Epidemiology, Clinical Aspects & Public Health Responses
Funder
National Health and Medical Research Council
Funding Amount
$120,659.00
Summary
The 2009 flu pandemic exposed gaps in Australia's surveillance & public health policies. Using a hospital surveillance system (FluCAN) set up after the emergence of the pandemic virus, I will assess epidemiological, clinical & public health aspects of influenza to answer questions such as: what is the effectiveness of the influenza immunisation program? What is the burden of disease of severe influenza? Which forms of surveillance are best for different settings in Australia & in Asia-Pacific?
Improving Patient Access To Novel Cancer Drugs In Australia: Striking The Balance
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Cancer patients in Australia may experience delays before they can benefit from new expensive drugs because of the lengthy existing processes to evaluate new medicines by the Department of Health. I will study how to improve the existing drug evaluation processes to make timely but informed funding decisions. This work will improve patient outcomes from early access to effective new cancer drugs and help the government make a wiser spending of public funds.
Piloting, Implementing And Evaluating First Few Hundred Protocols In The Australian Context
Funder
National Health and Medical Research Council
Funding Amount
$1,497,570.00
Summary
The World Health Organisation identifies pandemic influenza as one of ten top threats to human health in 2019. Australia has invested extensively in preparedness planning, but gaps remain. We do not presently have finalised study protocols to collect evidence from early identified cases and household contacts in a pandemic, information needed to inform targeted public health responses. We will work across governments and settings to test and advise on these study protocols for all Australians.
What Works To Reduce Aboriginal And Torres Strait Islander Smoking? A National Evaluation Of Tobacco Control Initiatives For Aboriginal And Torres Strait Islander People
Funder
National Health and Medical Research Council
Funding Amount
$120,603.00
Summary
My study ties in with a large national project that aims to find out what works to reduce smoking among Aboriginal and Torres Strait Islander people. I will look specifically at one tobacco control approach and its effect on steps toward quitting and staying quit in this group. Together with findings from the broader study, this research will provide valuable new information to help reduce smoking, the number one killer for Aboriginal and Torres Strait Islander people.
I lead an internationally recognised research program that examines how governments can best respond to alcohol and illegal drugs – a significant health and social problem in Australia. My research generates new evidence to inform drug policy and I study how to translate research into meaningful information that governments can use. My aim is to improve how Australia responds; reducing the community harms and improving the health of those affected by alcohol and drugs.
Transformed Drug Policies: Integrating Empirical Evidence With Participatory Democracy
Funder
National Health and Medical Research Council
Funding Amount
$782,370.00
Summary
In my 5 year research fellowship I will lead internationally relevant research on better policy options for illegal drugs, such as methamphetamine, heroin and cannabis. Drug policy can be driven by politics and the media, rather than research evidence. I will generate a cutting edge and fresh perspective with an agile approach to new research that takes into account the rapidly changing field of drug policy. This will provide policy makers with a new framework for evidence-based policy reforms.
Addressing Conflicts Of Interest In Public Health And Biomedicine: Enhancing Professional Integrity And Safeguarding The Public’s Health
Funder
National Health and Medical Research Council
Funding Amount
$583,014.00
Summary
It is common for health researchers, clinicians and policymakers to have "conflicts of interest" due, for example, to relationships with private industry. It is widely accepted that conflicts of interest can at times distort research, policymaking and practice, but there is no consensus as to how they should be conceptualised, assessed or managed In this project we will explore the causes and impacts of conflict of interest, and devise a sophisticated framework for managing them.